HALO
Halozyme Therapeutics Inc.

4,822
Loading...
Loading...
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
350

Frequently Asked Questions

What is Market Cap of Halozyme Therapeutics Inc.?
What is the 52-week high for Halozyme Therapeutics Inc.?
What is the 52-week low for Halozyme Therapeutics Inc.?
What is Halozyme Therapeutics Inc. stock price today?
What was Halozyme Therapeutics Inc. stock price yesterday?
What is the PE ratio of Halozyme Therapeutics Inc.?
What is the Price-to-Book ratio of Halozyme Therapeutics Inc.?
What is the 50-day moving average of Halozyme Therapeutics Inc.?
How many employess does Halozyme Therapeutics Inc. has?

Latest HALO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.